Digital MediYoga for quality of life and heart measures in paroxysmal atrial fibrillation
Official title: The Effect of MediYoga on Quality of Life, Blood Pressure and Heart Rate Among Patients With Atrial Fibrillation: A Randomized Controlled Trial
Run by Herlev and Gentofte Hospital · NCT07321964 · Data updated 2026-11-12
This trial will test whether a 12-week, app-delivered MediYoga program can improve disease-specific quality of life and reduce blood pressure and heart rate in adults with paroxysmal atrial fibrillation.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 456 (estimated) |
| Sponsor | Herlev and Gentofte Hospital Academic / other |
| Locations | 1 site (Herlev) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | September 1, 2028 |
| Registry record updated | January 7, 2026 |
| Trial ID | NCT07321964 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a diagnosis of paroxysmal atrial fibrillation, EHRA score ≥2, who own a smartphone or tablet, read and speak Danish, and have no comorbidity that prevents participation are ideal candidates.
✕Probably not a fit
Patients with significant comorbidities that restrict physical activity, elevated TSH, those who regularly practiced mindfulness or yoga in the past two years, or those who cannot read/speak Danish are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial enrolls 456 adults with paroxysmal atrial fibrillation and an EHRA score of 2 or higher to compare a 12-week digital MediYoga program (delivered via smartphone app with online Teams support) versus usual care. The intervention includes guided low-intensity yoga, deep breathing, and meditation sessions of differing lengths (20 or 60 minutes). Data are collected at baseline, 3, 6, and 12 months, with the primary outcome being disease-specific quality of life and secondary outcomes including blood pressure, heart rate, generic quality of life, and psychological wellbeing. Qualitative interviews will also explore participants' experiences and acceptability of the digital program.
Why it matters
Potential benefit: If successful, the program could improve symptoms and disease-specific quality of life and also help lower blood pressure and resting heart rate in people with paroxysmal AF.
How similar studies have gone: Smaller and pilot studies of yoga and breathing-based interventions for AF and cardiovascular outcomes have shown promising effects on symptoms, stress, and blood pressure, but large fully digital randomized trials are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 and above * Diagnosed with paroxysmal atrial fibrillation * EHRA score at 2 or more * Owner of a smartphone or tablet * Speaking and reading Danish * No comorbidity that restricts them from participating in the intervention Exclusion Criteria: * Elevated TSH Hormone * Participated in mindfulness or yoga exercise regularly at any point during the last two years.
Where it's running
-
Herlev and Gentofte University Hospital
Herlev, Denmark Recruiting
Study contacts
- Study coordinator: Signe S Risom, Associated Professor
- Email: signe.stelling.risom@regionh.dk
- Phone: +45 5163 2786
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Progressive Resistance Training First to Help AF and HFpEF Patients Feel Better
This trial tests whether starting with progressive resistance training before aerobic exercise can improve exercise capacity and quality of life in people aged 60 and older who have atrial fibrillation and HFpEF.
-
Effects of Alcohol Consumption on Atrial Fibrillation Episodes
This study is testing whether drinking small to moderate amounts of alcohol affects how often people with paroxysmal atrial fibrillation have episodes of irregular heartbeats.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.